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BACKGROUND
An increasing number of links have recently been found
between neurological diseases and inflammatory bowel
diseases, including Crohn's disease.  Neurological
manifestations are seen in anywhere between 0.2-35.7%
of patients with Crohn's disease, and are mainly related to
cerebrovascular disease.  Epilepsy has been quoted to be
responsible for 15-50% of the neurological involvement in
Crohn's disease patients.1,2 The underlying process for the
se izures and epi lepsy is  thought  to be re lated to
inflammatory or hypercoagulable mechanisms, but this is
not well understood.2 Recently, a genetic basis has been
discovered for Crohn's  disease. Numerous genetic
etiologies have also been found in relation to seizures and
epilepsy. Because both disorders have known genetic
etiologies, the possibility exists that a common genetic link
may exist. We reviewed one hundred fifty consecutive
charts from our adult epilepsy clinic at the University of
Alberta Hospital, to identify patients with Crohn's disease,
and analyzed these patients' family history for the
presence of Crohn's disease or epilepsy.
CASE DESCRIPTIONS
Of the one hundred and fifty patients in our epilepsy clinic,
four patients were found with Crohn's disease. The
population prevalence of Crohn's disease has been
estimated between 26 to 198.5 per 100,000 individuals,
with Canadian data at the higher end of this estimate.3,4
Thus, the prevalence within our epilepsy clinic is higher
than what would be expected based on the population
prevalence. We also included another patient without
Crohn's disease, but with a pronounced family history of
both Crohn's disease and seizures. 
Case 1: A fifty-four year old right-handed woman with
seizures since age nineteen. She described these events
as brief periods of altered consciousness.  Each episode
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ABSTRACT:
Background: Seizures are described in Crohn's disease. The etiology of these seizures is unclear but is thought to be
related to inflammatory or hypercoagulable mechanisms. We have found a group of patients with both epilepsy and Crohn's
disease, without significant abnormalities on imaging, raising the possibility of a genetic link. A genetic etiology has been
described in Crohn's disease, specifically in relation to IBD 1 (NOD2) gene. Many genetic defects have also been found to
increase susceptibility to seizures.  We explored these cases to find support for a possible genetic link between seizures and
Crohn's disease. 
Methods: Case series/Literature review.
Case descriptions: Four patients of the 150 patients in our epilepsy clinic were identified with Crohn's disease, a much
higher prevalence than would be expected from population prevalence of the disease. The case presentations of these
patients are described, as well as an additional patient not affected by Crohn's but with a strong family history of the
condition. The patients' family histories are explored.  All of our patients have positive family histories of either seizures or
Crohn's disease. Two of the patients have family histories both of seizures and Crohn's disease.
C o n c l u s i o n : Genetic associations have been described for both seizures and Crohn's disease. Coexistence of two
genetically transmitted diseases, such as Crohn's disease and epilepsy, can help in chromosomal and genetic localization.
Our case series raises the possibility of this association and can serve as a nidus for future research.
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would only last for a second. She denied ever having lost
consciousness, but had bitten her tongue while asleep.
She had briefly been treated with phenytoin when she was
nineteen, but was unable to tolerate the medication. She
recalled that when she was a teenager, her teachers told
her that she was frequently “daydreaming”. The patient's
past medical history was remarkable for Crohn's disease.
The patient's son also suffered from seizures, beginning
when he was 18 months old. Her son also had Crohn's
disease. Two of her nieces had also had problems with
seizures. 
The patient's magnetic resonance imaging (MRI) scan was
unremarkable. Her electroencephalogram (EEG) revealed
generalized epi leptiform discharges in a bif rontal
distr ibution. She was diagnosed wi th  id iopathic
generalized epilepsy and started on valproic acid.
Case 2: A thirty-five year old right-handed man with
newly diagnosed seizures.  The patient had returned home
from work unable to recall the day's events, and that
evening had a witnessed generalized tonic-clonic seizure.
The patient had been diagnosed with Crohn's disease ten
years previously, treated with a bowel resection.  He also
carried diagnoses of asthma and psoriasis.  The patient's
family history includes two maternal great-uncles with
epilepsy and his father also has psoriasis.  The patient's
MRI was unremarkable.  His EEG showed right temporal
slowing and sharp waves.  He was diagnosed with
localization related epilepsy, and is being managed with
carbamazepine.
Case 3: A thirty-one year old right-handed man with a
history of seizures since age fourteen.  The patient
described two types of seizures. His “mild episodes” would
last for about thirty seconds, in which he would stare,
swallow, and pick up objects.  The patient would also have
genera lized tonic-clonic seizures, and had been
hospitalized with status epilepticus on one occasion.  The
patient also had Crohn's disease. His past history was
otherwise unremarkable. The patient had a brother with
both Crohn's disease and psoriasis. He also had two
maternal aunts who were also diagnosed with Crohn's
disease. He also had a second cousin with seizures, and
another second cousin with Crohn's disease. The MRI was
unremarkable. He had multiple EEG's, demonstrating
epileptic discharges in both temporal regions. A single
photon emission computed tomography (SPECT) scan
showed increased cortical perfusion in the anterior inferior
frontal cortex. Because of no demonstrable lesion on MRI,
it was decided he should continue with medical therapy. 
Case 4: A thirty-four year old right-handed woman who
had been recently diagnosed with seizures. The episodes
came with little warning, involving loss of consciousness
with generalized tonic-clonic seizures and loss of bladder
control. The patient was briefly cyanotic at birth, was
slightly developmentally delayed and required special
education classes. The patient had no family history of
seizures, but her mother, brother, maternal grandmother,
and maternal aunt had all been diagnosed with Crohn's
disease. The patient's MRI revealed mild white matter
loss. Her EEG showed a single burst of bifrontal activity.
She was diagnosed with localization related epilepsy, and
was treated with carbamazepine. 
Case 5: A thirty-two year old right-handed man who had
seizures since the age of twelve. The patient reported
having several “small seizures” as well as generalized
tonic-clonic seizures. He described his seizures as
occurring with an aura including déjà vu and an epigastric
sensation, and would then stare into space.  He was able
to speak during seizures. Most often his seizures occurred
on awakening. Sleep deprivation would lead to more
seizures. The seizures were being treated with valproic
acid and topiramate. The patient's past medical history
included psoriasis as well as mild cyanosis at birth, but no
known birth injury. The patient's family history was
interesting. He had a sister who suffered seizures as a
child until the age of 5. His father and many paternal
uncles had been diagnosed with Crohn's disease. The
patient's physical examination was unremarkable. No
intracerebral lesions were seen on MRI. EEG revealed
epileptiform activity in the left temporal region.  
DISCUSSION
Recently, a lot of work has been done on the genetics of
inflammatory bowel disease, especially Crohn's disease.
Multiple gene loci have been identified. The most studied
has been the IBD1 locus, identified first by Hugot et al. in
1 9 9 6 .5 This gene locus has specifically been associated
with Crohn's disease. It is located on chromosome 16q21,
and contains the NOD2/capase-activation recruitment
domains 15 (CARD15) gene. This gene is expressed in
peripheral blood monocytes and is thought to be involved
in host resistance to microbial pathogens. The three major
polymorphisms associated wi th Crohn's disease
(Arg702Trp, Gly908Arg, and Leu1007fsinsC) are located
in the portion of the gene that encodes for the pattern-
recognition receptor, which recognizes many types of
microb ial  components,  including bacterial
l i p o p o l y s a c c h a r i d e s .6 Having one copy of the abnormal
allele increases the patient's risk of Crohn's disease two to
four fold, and having two abnormal alleles increases the
risk twenty to forty fold.6 The IBD2 locus has been
identified on chromosome 12q13, but it has been only
inconsistently replicated, and its gene product has yet to
be identified.7 The IBD3 locus on chromosome 6p13 likely
encodes for major histocompatibility complex, and allelic
foci have been found within this locus in relation to both
Crohn's disease and ulcerative colitis. The specific gene
involved has been difficult to find, as with other diseases
with a HLA component.7 Other important genes appear to
be in this region.  The tumor necrosis factor (TNF) gene is
also located in this region6, and has been linked to both
Crohn's disease as well as other inflammatory conditions.
Interesting and relevant to epilepsy, a genetic defect in
patients with juvenile myoclonic epilepsy has also been
studied near this gene locus, on chromosome 6p11-12,
called EJM1.8 Many other gene loci are also under
investigation, and results look promising to finding even
more related genetic defects. 
Genetic loci have also been found in relation to seizures
and epilepsy.  More than seventy gene loci have already
been identified.9 Broadly, these can be classified into
symptomatic epilepsies, in which an underlying structures
defect can be identified, and idiopathic epilepsies, where
no defect can be found. Multiple and diverse genetic
defects have been found in the first group, ranging from
progressive myoclonic epilepsies such as Lafora body
disease and the EPM2 gene, to neuronal migration
disorders such as subcortical band heterotropia and the
DCX gene. In contrast, the majority of genetic defects in
the idiopathic epilepsies relate to channelopathies.9 , 1 0
However, the discovered genetic influences to date only
make up a small group of the familial epilepsies, and the
remainder appears to have a more complex non-Medelian
inheritance. 
Common links between disorders has become important
in determining responsible genetic defects. Recently, a lot
of interest has been generated surrounding a possible
genetic link between psoriasis and Crohn's disease.
Crohn's disease patients have approximately a 7-fold
increase chance of also developing psoriasis.1 1 T h i s
raised the possibility of a genetic linkage between the two
conditions, especially in relation to the IBD1 gene locus.
Unfortunately, a large linkage study found no association
between the two conditions for the Leu1007fsinsC
v a r i a n t .1 2 However, more studies searching for other
allelic variants will have to be performed before ruling out
a link.  In addition, tumor necrosis factor has been found
to have a significant role in both conditions, and a
common genet ic defect in th is  gene may also be
significant, especially for therapeutic implications.13
A similar connection may be found between Crohn's
disease and epilepsy. Currently, many neurological
disorders have been linked to Crohn's disease, mainly on
inflammatory or hypercoagulable mechanisms.2 T h e s e
disorders include cerebrovascular disease, myelopathy,
peripheral neuropathy, and a multiple sclerosis-like
syndrome.14 Seizures and epilepsy have also been linked
on these grounds, but our group of patients raises an
interesting possibility of a genetic link between the two
conditions outside of these mechanisms. Determining a
connection would not only link the two conditions allowing
a better understanding of  the underlying
pathophysiological mechanisms, but may also have
therapeutic implications, as is the case with Crohn's
disease and psoriasis and the use of infliximab, a
monoclonal antibody directed against tumor necrosis
factor alpha.15
CONCLUSION
This case series provides an anecdotal and potential
relationship between epilepsy and Crohn's disease.
Seizures noted in patients with Crohn's disease are usually
attributed to cerebrovascular accidents, and we did not
come across any published data exploring or even
questioning a possible genetic link between these two
conditions.  In our epilepsy clinic, there are definitely an
increased number of patients with Crohn's disease than
would be expected from its population prevalence. It is
also interesting that in all the patients we identified, some
evidence of a family history of seizures or Crohn's disease
is also found. All these patients underwent investigation
with MRI. In light of the normal imaging, we are suspicious
of a possible genetic link between these two conditions.
Whatever the case, this area should provide exciting
research in the future.  We plan to work with our
inf lammatory bowel d iseases' c l in ic  to study the
prevalence of seizures in patients with Crohn's disease.  
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